<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

The Clinical Choice of Sedative-Hypnotics

descriptionPublicationkeyboard_double_arrow_right Article 01 Jul 1972 English Publisher:American College of PhysiciansJournal:Annals of Internal Medicine, volume 77, pages 91-100 (issn: 0003-4819, eissn: 1539-3704,

Authors: David J. Greenblatt; Richard I. Shader;

doi: 10.7326/0003-4819-77-1-91 , 10.1097/00006254-197302000-00011

pmid: 4340727

The Clinical Choice of Sedative-Hypnotics

- Summary
- Subjects
- Metrics

Abstract

Abstract The clinician is faced with a bewildering array of available sedatives, hypnotics, and tranquilizers, as well as continuous pressure from patients, the popular media, and the pharmaceutica...

Keywords

Diazepam, Chlorpromazine, Oxazepam, Guinea Pigs, Anticoagulants, Sleep, REM, Chlordiazepoxide, Phenindione, Rats, Ethchlorvynol, Enzyme Induction, Barbiturates, Animals, Glutethimide, Humans, Hypnotics and Sedatives, Meprobamate, Drug Interactions, Methaqualone, Chloral Hydrate

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	54
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%